What the ACTH(4-7) Sequence Means in Semax Research

What the ACTH(4-7) Sequence Means in Semax Research

What the ACTH(4-7) sequence means in Semax research is that the first four residues of Semax, Met-Glu-His-Phe, reproduce amino acids 4 through 7 of native adrenocorticotropic hormone. This short ACTH-derived segment gives Semax its melanocortin-fragment lineage, but it does not contain the complete ACTH hormonal sequence or the full His-Phe-Arg-Trp melanocortin receptor-recognition motif, so ACTH(4-7) ancestry should not be treated as evidence that Semax behaves like intact ACTH.

The ACTH(4-7) sequence provides a structural anchor within Semax Research. Examining Met-Glu-His-Phe residue by residue helps clarify what Semax inherited from ACTH, what was discarded during peptide design, and why the final heptapeptide should be studied independently.

Research-use notice: InStrips products are offered for research and analytical use only. They are not intended to diagnose, treat, cure, or prevent any disease, injury, deficiency, absorption disorder, digestive condition, or medical condition.

ACTH(4-7) Is Met-Glu-His-Phe

The notation can be expanded as:

  • ACTH position 4: methionine
  • ACTH position 5: glutamate
  • ACTH position 6: histidine
  • ACTH position 7: phenylalanine

Together:

Met-Glu-His-Phe

These Become Semax Residues 1 Through 4

Once isolated from ACTH and incorporated into Semax, the fragment occupies the N terminus:

  • Semax position 1: Met
  • Semax position 2: Glu
  • Semax position 3: His
  • Semax position 4: Phe

The numbering changes because the synthetic peptide begins at ACTH residue 4.

This Numbering Difference Can Cause Confusion

For example, “His6” in ACTH and “His3” in Semax refer to the same histidine residue in terms of sequence ancestry.

Research writing should make clear which numbering system is being used.

Methionine Begins the Semax Molecule

Methionine becomes the free N-terminal residue of Semax.

In native ACTH, residue 4 is internal and does not possess a free N-terminal amino group.

This Means the Same Methionine Has a Different Chemical Context

Removing residues 1 through 3 of ACTH changes the chemistry around Met4.

In Semax, its N-terminal amino group can influence:

  • charge
  • metal coordination
  • enzyme recognition
  • chemical modification

Fragmentation Can Therefore Create New Properties

A residue copied from a parent hormone does not necessarily behave identically after becoming a terminus of a shorter peptide.

Molecular context matters.

Methionine Contains a Sulfur Atom

The methionine side chain includes a thioether group.

Under oxidative conditions, methionine can potentially form oxidized species.

Whether this occurs substantially in Semax depends on formulation and experimental environment.

Oxidized Semax Would Be a Modified Molecular Form

Methionine oxidation changes molecular mass and polarity.

Analytical methods should therefore distinguish parent peptide from oxidative degradation products where stability is being investigated.

Glutamate Is the Second Semax Residue

Glutamate contains an acidic side chain.

At many biological pH values it contributes negative charge.

That Acidic Residue Affects the N-Terminal Region

The close placement of:

  • a positively charged or protonatable N terminus
  • a negatively charged glutamate side chain

creates a mixed electrostatic environment within the first two residues.

Histidine Is Residue Three of Semax

Histidine contains an imidazole side chain capable of:

  • protonation and deprotonation near biologically relevant pH ranges
  • hydrogen bonding
  • metal coordination

Histidine Is Important in Semax Metal-Binding Research

Studies of Cu(II) coordination have examined the Semax N-terminal region because the free amino group and histidine provide potential donor atoms.

Those experiments demonstrate that ACTH-derived residues can contribute chemical properties beyond their original hormonal sequence context.

Copper Coordination Is a Separate Research State

A Cu(II)-Semax complex and metal-free Semax are not identical chemical systems.

Metal-binding research should specify:

  • metal identity
  • oxidation state
  • pH
  • peptide-to-metal ratio

Phenylalanine Completes ACTH(4-7)

Phenylalanine contains a hydrophobic aromatic side chain.

It occupies position 7 in ACTH and position 4 in Semax.

Phe Is Also Part of the Broader Melanocortin Recognition Region

In intact ACTH, the nearby sequence includes:

His6-Phe7-Arg8-Trp9

This HFRW motif is highly important in classical melanocortin-receptor pharmacology.

Semax Interrupts the HFRW Sequence After Phe

The corresponding Semax region is:

His-Phe-Pro-Gly

Arg and Trp have been replaced through the PGP extension design.

This Is One of the Most Important Boundaries in Semax Terminology

Semax is ACTH derived, but it does not contain the complete canonical HFRW melanocortin pharmacophore.

Therefore, full ACTH receptor activity cannot simply be assumed from the presence of His-Phe.

MC2R Pharmacology Is Especially Important to Separate

ACTH has a distinctive endocrine role through melanocortin 2 receptor signalling in the adrenal cortex.

Semax's four-residue ACTH-derived segment does not establish that the finished heptapeptide reproduces this interaction.

Hormonal Activity and Sequence Homology Are Different Questions

A fragment can resemble a hormone structurally while lacking key determinants required for its classical endocrine action.

This is precisely why fragment-based peptide research can separate biological functions.

ACTH(4-7) Is Shorter Than the Minimal Classical Melanocortin Core

The four-residue fragment contains:

MEHF

whereas the HFRW pharmacophore begins within it but extends beyond it.

ACTH(4-7) therefore captures only part of the classical receptor-recognition region.

The Fragment Has Its Own Historical Research Literature

ACTH fragments were investigated for central and behavioural effects independently of the endocrine actions of intact ACTH.

This history contributed to the design logic behind Semax.

Fragment Findings Should Still Be Kept Separate From Semax Findings

ACTH(4-7) ends with phenylalanine.

Semax continues:

Phe-Pro-Gly-Pro

The extra residues alter the molecule's C terminus and degradation profile.

The PGP Extension Changes How the ACTH Fragment Is Presented

Adding PGP can affect:

  • conformation around Phe
  • terminal protease susceptibility
  • overall molecular persistence
  • metabolites formed during degradation

This Makes ACTH(4-7) a Building Block, Not a Synonym

A useful description is:

Semax contains ACTH(4-7).

A less accurate description would be:

Semax is ACTH(4-7).

The second statement ignores almost half of the final peptide.

ACTH(4-7) and PGP Can Be Studied Separately

Separating the components allows researchers to ask whether a measured response depends more strongly on:

  • the ACTH-derived N terminus
  • the PGP tail
  • the intact seven-residue molecule

This Requires Matched Experimental Conditions

A valid structural comparison should consider:

  • molar concentration
  • exposure time
  • model
  • analytical endpoint

Otherwise, differences may reflect experimental design rather than peptide structure.

PGP Alone Does Not Reproduce Every Semax Observation

Experimental comparisons have reported outcomes in which PGP and Semax differ.

For example, a rat cerebral-ischemia study found that the isolated PGP fragment did not reproduce the complete Semax response measured in that model.

This Supports Intact-Peptide Specificity for Some Endpoints

The result does not prove that every Semax effect comes exclusively from ACTH(4-7).

Instead, it demonstrates that the contribution of each structural region is endpoint dependent.

PGP Can Have Independent Biological Activity in Other Models

Other studies have reported molecular effects from PGP alone.

Thus, the PGP extension should not be considered biologically inert simply because one endpoint depends on the full Semax molecule.

Structure-Activity Interpretation Needs More Than One Comparison

An informative design might compare:

  • vehicle
  • ACTH(4-7)
  • PGP
  • Semax
  • ACTH(4-10)

This can help identify structural contributions more precisely.

Metabolites Can Resemble These Comparator Peptides

Semax degradation can generate shorter fragments.

A detected ACTH-related or PGP-related fragment after Semax exposure should not automatically be interpreted as evidence that the parent peptide remains intact.

Parent Peptide and Metabolite Concentrations Are Different Variables

A rigorous pharmacokinetic study may attempt to quantify:

  • intact Semax
  • major N-terminal fragments
  • PGP-associated fragments

A Biological Response Can Outlast the Parent Peptide

If Semax initiates gene transcription or another signalling cascade, the resulting molecular changes can persist after the parent heptapeptide has been degraded.

This means response duration should not be used as a direct estimate of peptide half-life.

ACTH(4-7) Also Helps Explain Why Semax Is Not ACTH

Only four of ACTH's 39 residues are retained directly.

A compound sharing roughly one short sequence segment with a parent hormone should not inherit the parent hormone's complete:

  • receptor profile
  • pharmacokinetics
  • endocrine function
  • clinical evidence

The Same Principle Applies to Alpha-MSH

ACTH and alpha-melanocyte-stimulating hormone share an N-terminal sequence relationship because both derive from POMC-associated melanocortin biology.

Semax's ACTH-derived residues should not make the peptide interchangeable with alpha-MSH either.

Sequence Homology Needs a Defined Denominator

Saying that Semax is “ACTH-like” is incomplete without explaining:

  • which residues are shared
  • which residues are different
  • which receptor motif is retained
  • which motif is disrupted

The ACTH(4-7) Sequence Is Also Relevant Analytically

Mass-spectrometric fragmentation can produce ions corresponding to the N-terminal ACTH-derived region.

Such ions can support sequence identification when combined with the expected parent mass.

One Fragment Ion Is Not Complete Identity Proof

Strong analytical identification can combine:

  • precursor mass
  • multiple fragment ions
  • chromatographic retention
  • reference material

N-Terminal Modification Changes the ACTH(4-7) Region Directly

Acetylating Semax modifies the methionine N terminus that originated from ACTH residue 4.

This changes the chemical behavior of the very region retained from the parent hormone.

Therefore Ac-Semax Requires Its Own Name

Published research has shown that N-terminal acetylation can change Semax metal-coordination behavior.

Modified analogues should not be treated as analytically identical to unmodified MEHFPGP.

Sequence Identity Does Not Establish Clinical Effectiveness

Knowing precisely that Semax contains MEHF establishes structural ancestry.

It does not establish:

  • clinical effectiveness
  • cognitive enhancement
  • neuroprotection in people
  • general safety
  • personal-use suitability

ACTH Research Cannot Fill Semax Evidence Gaps

A well-established effect of intact ACTH is not automatically evidence for Semax.

The molecules differ drastically in size, sequence, receptor determinants, and endocrine context.

ACTH(4-10) Research Also Requires Careful Attribution

ACTH(4-10) provides a close structural comparator, but its sequence is MEHFRWG rather than MEHFPGP.

Findings should remain attached to the exact heptapeptide used.

The PGP Extension Is the Next Design Question

Once the significance of MEHF is established, the next question is why Semax ends in Pro-Gly-Pro and how that affects the finished molecule.

This is examined in Why the Pro-Gly-Pro Extension Matters in Semax Peptide Design.

Reading a Compound-Specific ACTH-Lineage Study

The PubMed-indexed paper Semax, an ACTH4-10 Peptide Analog With High Affinity for Copper(II) Ion and Protective Ability Against Metal Induced Cell Toxicity explicitly defines Semax as a heptapeptide containing the ACTH(4-7) N-terminal sequence followed by Pro-Gly-Pro.

Its structural characterization helps establish what ACTH(4-7) means within the Semax molecule. The paper's metal-binding and cell-model results should remain separate from claims about general clinical effectiveness or personal use.

Final Perspective

The ACTH(4-7) sequence in Semax is Met-Glu-His-Phe, the four-residue N-terminal block inherited directly from ACTH positions 4 through 7.

Those residues provide Semax's ACTH and melanocortin-fragment lineage, but the fragment lacks the complete HFRW melanocortin recognition motif and represents only a small portion of intact 39-residue ACTH. Its chemical context is also changed because ACTH residue 4 becomes the free N terminus of the synthetic peptide.

Accurate Semax research should therefore treat ACTH(4-7) as a structural building block within MEHFPGP, not as evidence that Semax is equivalent to ACTH, ACTH(4-10), alpha-MSH, or another melanocortin peptide.

Back to blog